AGP Picks
View all

Catch up with science and technology news from Haiti

Provided by AGP

Haiti, Science, & Me: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Haiti, Science, & Me.

Press releases published on May 14, 2026

ESW Launches Microsoft 365 AI Readiness Audits and Roadmaps to Help Companies Move Faster With AI
Tonix Pharmaceuticals to Present Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at ISPOR 2026
EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU™, Building Confidence Ahead of Mid-2026 Topline Data
illumin and Cint make brand measurement immediate and actionable in programmatic advertising
Kashable Collaborates with E4E Relief to Advance Comprehensive Financial Safety Nets for Employees in Need
BrewDog Shakes Up RTD Shelves Across the UK with New Nostalgia-Led Wonderland Cocktails
NETSOL Technologies reports record quarterly revenue and 13% year-over-year growth in Q3 fiscal 2026
Calian Reports Record Results for the Second Quarter of Fiscal 2026
Calian annonce des résultats record au deuxième trimestre de l’exercice 2026
Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress
Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting
Pelthos Therapeutics Announces First Quarter 2026 Financial Results
Hyperion DeFi Reports 1Q 2026 Financial Results with Record Net Income and Raises Guidance for Full Year 2026
Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones
Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting
Larimar Therapeutics Reports First Quarter 2026 Financial and Business Update
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report First Quarter 2026 Financial Results and Provide Corporate Update
Synack’s Analysis of 11,000+ Vulnerabilities Reveals Top Weaknesses Attackers Are Weaponizing Today
Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder

Share us

on your social networks:

Sign up for:

Haiti, Science, & Me

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.